IBDEI1FL ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=EXCISION^3^60
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=MISCELLANEOUS^5^60
 ;;^UTILITY(U,$J,358.4,623,0)
 ;;=POST-OP COMPLICATIONS^16^61
 ;;^UTILITY(U,$J,358.4,624,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^61
 ;;^UTILITY(U,$J,358.4,625,0)
 ;;=GYN/BREAST^8^61
 ;;^UTILITY(U,$J,358.4,626,0)
 ;;=MALE BREAST^10^61
 ;;^UTILITY(U,$J,358.4,627,0)
 ;;=BENIGN LESIONS OF SKIN^3^61
 ;;^UTILITY(U,$J,358.4,628,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^61
 ;;^UTILITY(U,$J,358.4,629,0)
 ;;=MELANOMA^12^61
 ;;^UTILITY(U,$J,358.4,630,0)
 ;;=LACERATIONS^9^61
 ;;^UTILITY(U,$J,358.4,631,0)
 ;;=MERKEL CELL CANCER^13^61
 ;;^UTILITY(U,$J,358.4,632,0)
 ;;=AFTERCARE POST SURGERY^2^61
 ;;^UTILITY(U,$J,358.4,633,0)
 ;;=CARDIOVASCULAR^4^61
 ;;^UTILITY(U,$J,358.4,634,0)
 ;;=ENT^5^61
 ;;^UTILITY(U,$J,358.4,635,0)
 ;;=ABDOMINAL PAIN^1^61
 ;;^UTILITY(U,$J,358.4,636,0)
 ;;=GI^7^61
 ;;^UTILITY(U,$J,358.4,637,0)
 ;;=RESPIRATORY^17^61
 ;;^UTILITY(U,$J,358.4,638,0)
 ;;=ORTHOPEDIC^14^61
 ;;^UTILITY(U,$J,358.4,639,0)
 ;;=PLASTIC SURGERY^15^61
 ;;^UTILITY(U,$J,358.4,640,0)
 ;;=UROLOGY^18^61
 ;;^UTILITY(U,$J,358.4,641,0)
 ;;=NEW PATIENT^2^62
 ;;^UTILITY(U,$J,358.4,642,0)
 ;;=ESTABLISHED PATIENT^1^62
 ;;^UTILITY(U,$J,358.4,643,0)
 ;;=CONSULTATIONS^3^62
 ;;^UTILITY(U,$J,358.4,644,0)
 ;;=COMPREHENSIVE ASSESSMENT/TREATMENT^1^63
 ;;^UTILITY(U,$J,358.4,645,0)
 ;;=VACCINE ADMINISTRATION^4^63
 ;;^UTILITY(U,$J,358.4,646,0)
 ;;=INJECTION ADMINISTRATION^2^63
 ;;^UTILITY(U,$J,358.4,647,0)
 ;;=INJECTIONS-DRUGS/MEDICATIONS^3^63
 ;;^UTILITY(U,$J,358.4,648,0)
 ;;=VACCINES^5^63
 ;;^UTILITY(U,$J,358.4,649,0)
 ;;=***MEDICAL***^2^64
 ;;^UTILITY(U,$J,358.4,650,0)
 ;;=***PSYCHIATRIC***^3^64
 ;;^UTILITY(U,$J,358.4,651,0)
 ;;=***ALZHEIMERS***^1^64
 ;;^UTILITY(U,$J,358.4,652,0)
 ;;=NEW PATIENT HOME VISIT^2^65
 ;;^UTILITY(U,$J,358.4,653,0)
 ;;=ESTAB PATIENT HOME VISIT^1^65
 ;;^UTILITY(U,$J,358.4,654,0)
 ;;=TEAM CONFERENCE^8^66
 ;;^UTILITY(U,$J,358.4,655,0)
 ;;=PROCEDURE CODE^6^66
 ;;^UTILITY(U,$J,358.4,656,0)
 ;;=EDUCATION/TRAINING^1^66
 ;;^UTILITY(U,$J,358.4,657,0)
 ;;=IMMUNIZATIONS^2^66
 ;;^UTILITY(U,$J,358.4,658,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^3^66
 ;;^UTILITY(U,$J,358.4,659,0)
 ;;=SKIN TEST^7^66
 ;;^UTILITY(U,$J,358.4,660,0)
 ;;=PREVENTIVE MED-EST PT^4^66
 ;;^UTILITY(U,$J,358.4,661,0)
 ;;=PREVENTIVE MED-NEW PT^5^66
 ;;^UTILITY(U,$J,358.4,662,0)
 ;;=CARDIOVASCULAR^3^67
 ;;^UTILITY(U,$J,358.4,663,0)
 ;;=ENDOCRINE/METABOLIC^7^67
 ;;^UTILITY(U,$J,358.4,664,0)
 ;;=PULMONARY^21^67
 ;;^UTILITY(U,$J,358.4,665,0)
 ;;=EENT^6^67
 ;;^UTILITY(U,$J,358.4,666,0)
 ;;=MUSCULOSKELETAL^15^67
 ;;^UTILITY(U,$J,358.4,667,0)
 ;;=NEURO^16^67
 ;;^UTILITY(U,$J,358.4,668,0)
 ;;=MENTAL HEALTH^14^67
 ;;^UTILITY(U,$J,358.4,669,0)
 ;;=GASTROENTEROLOGY^8^67
 ;;^UTILITY(U,$J,358.4,670,0)
 ;;=GU/RENAL^9^67
 ;;^UTILITY(U,$J,358.4,671,0)
 ;;=WOMEN'S HEALTH^24^67
 ;;^UTILITY(U,$J,358.4,672,0)
 ;;=HEMATOLOGY/ONCOLOGY^10^67
 ;;^UTILITY(U,$J,358.4,673,0)
 ;;=INFECTIOUS DISEASE^12^67
 ;;^UTILITY(U,$J,358.4,674,0)
 ;;=DERMATOLOGY^5^67
 ;;^UTILITY(U,$J,358.4,675,0)
 ;;=HISTORY OF ILLNESS^11^67
 ;;^UTILITY(U,$J,358.4,676,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^19^67
 ;;^UTILITY(U,$J,358.4,677,0)
 ;;=INJURY/TRAUMA^13^67
 ;;^UTILITY(U,$J,358.4,678,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^23^67
 ;;^UTILITY(U,$J,358.4,679,0)
 ;;=SEXUAL TRAUMA^22^67
 ;;^UTILITY(U,$J,358.4,680,0)
 ;;=PAIN^18^67
 ;;^UTILITY(U,$J,358.4,681,0)
 ;;=OTHER REASONS^17^67
 ;;^UTILITY(U,$J,358.4,682,0)
 ;;=COMMON DIAGNOSES^2^67
 ;;^UTILITY(U,$J,358.4,683,0)
 ;;=PREVENTIVE MEDICINE CODES^20^67
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^67
